MFAM
EDIT icon

Motley Fool Asset Management’s Editas Medicine EDIT Stock Holding History

Motley Fool Asset Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-32
Closed -$1K – 254
2021
Q4 		$1K Buy
+32
New +$1.1K ﹤0.01% 311
2021
Q3 		– Sell
-53,943
Closed -$3.06M – 165
2021
Q2 		$3.06M Sell
53,943
-2,900
-5% -$107K 0.2% 92
2021
Q1 		$2.39M Buy
56,843
+8,700
+18% +$496K 0.17% 96
2020
Q4 		$3.38M Buy
48,143
+8,700
+22% +$357K 0.25% 81
2020
Q3 		$1.11M Buy
39,443
+2,610
+7% +$85K 0.1% 114
2020
Q2 		$1.09M Buy
36,833
+3,190
+9% +$83.4K 0.11% 104
2020
Q1 		$667K Sell
33,643
-290
-0.9% -$7.31K 0.09% 116
2019
Q4 		$1M Sell
33,933
-1,160
-3% -$29K 0.11% 106
2019
Q3 		$798K Sell
35,093
-580
-2% -$14.4K 0.09% 112
2019
Q2 		$883K Buy
35,673
+580
+2% +$13.8K 0.1% 112
2019
Q1 		$858K Buy
35,093
+5,800
+20% +$131K 0.1% 110
2018
Q4 		$666K Buy
+29,293
New +$797K 0.09% 113

Other funds holding EDIT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Motley Fool Asset Management's EDIT Position: Q1 2022 in Review

Motley Fool Asset Management sold out of Editas Medicine (EDIT) in Q1 2022, closing a stake of 32 shares — an estimated $1K sold.

Motley Fool Asset Management first reported a position in EDIT in Q4 2018 and held it in 12 quarters. The position peaked at $3.38M in Q4 2020. 256 funds tracked by Wall St. Rank hold EDIT as of Q1 2022.

  • Motley Fool Asset Management reported no remaining Editas Medicine position as of Q1 2022 after selling out during the quarter.
  • Motley Fool Asset Management sold 32 Editas Medicine shares in Q1 2022, an estimated $1K.
  • Motley Fool Asset Management first reported a position in Editas Medicine in Q4 2018 and held it in 12 quarters.
  • Motley Fool Asset Management's Editas Medicine position peaked at $3.38M in Q4 2020.
  • 256 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2022.

Based on Motley Fool Asset Management's 13F filing for Q1 2022, filed 4 May 2022.